At EADV 2026, researchers reported 39% of 575 users had nails separating versus 9% of non-users. They say it shows association, not cause, and advise talking to a doctor.
Recap by typeshit. Full story at Science Daily.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
The post grants GLP-1 drugs may help people with real health needs but warns of a negative effect, without saying what it is in the preview.
Facing Lilly's competition, Novo's chief is pitching muscle preservation and broader health gains as the measure that matters in obesity treatment.
Loading…